You are here

Eli Lilly

Pfizer, Lilly to mull anti-NGF mAb's future after joint safety events spike in long-term readout

Pfizer, Lilly to mull anti-NGF mAb's future after joint safety events spike in long-term readout

BioCentury

Flag link:

BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models

BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models

Fierce Biotech

Boehringer Ingelheim

type 2 diabetes

Flag link:

Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study

Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study

Yahoo/Reuters

clinical trials

osteoarthritis of the knee

Flag link:

The top 15 pharma companies by 2018 revenue

The top 15 pharma companies by 2018 revenue

Fierce Pharma

Bristol-Myers Squibb

Gilead Sciences

Teva Pharmaceutical

Flag link:

Big Pharma come together for better drug side effect detection

Big Pharma come together for better drug side effect detection

Pharma Times

Bristol-Myers Squibb

Gilead Sciences

International Working Group on Signal Detection and Management in Pharmacovigilance

pharmacovigilance

Flag link:

Eli Lilly joins a troika of Big Pharmas that have tied up to a low-profile biotech with big aspirations in autoimmune disease, cancer

Eli Lilly joins a troika of Big Pharmas that have tied up to a low-profile biotech with big aspirations in autoimmune disease, cancer

Endpoints

Flag link:

Lilly reveals Humalog pricing details amid larger scrutiny over insulin costs

Lilly reveals Humalog pricing details amid larger scrutiny over insulin costs

Biopharma Dive

Flag link:

Lilly's $7M tax abatement in Indianapolis draws bipartisan pushback: reports

Lilly's $7M tax abatement in Indianapolis draws bipartisan pushback: reports

Fierce Pharma

Flag link:

R&D round-up: Non-opioid painkiller space heats up

R&D round-up: Non-opioid painkiller space heats up

Pharmaforum

non-opioid pain treatments

Kings College London

Flag link:

Lilly CEO David Ricks snags $17.2M pay package for 2018, a 9% hike

Lilly CEO David Ricks snags $17.2M pay package for 2018, a 9% hike

Fierce Pharma

Flag link:

Lilly's combo treatment meets main goal in lung cancer late-stage study

Lilly's combo treatment meets main goal in lung cancer late-stage study

Yahoo/Reuters

clinical trials

metastatic non-small cell lung cancer

Flag link:

How Much Difference Will Eli Lilly's Half-Price Insulin Make?

How Much Difference Will Eli Lilly's Half-Price Insulin Make?

NPR

Flag link:

3 Big Pharmas Trying to Pop the Rebate Bubble

3 Big Pharmas Trying to Pop the Rebate Bubble

Motley Fool

Gilead Sciences

Flag link:

Lilly claims fast FDA review for Emgality in cluster headache

Lilly claims fast FDA review for Emgality in cluster headache

Pharmaforum

episodic cluster headache

Flag link:

Lilly will sell a version of its popular insulin at half the price, but will this appease critics?

Lilly will sell a version of its popular insulin at half the price, but will this appease critics?

Stat

Flag link:

In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data

In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data

Endpoints

Flag link:

Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod

Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod

Fierce Pharma

Flag link:

Biogen, BioMarin, Lilly and Bristol-Myers Could Be in Crosshairs of Acquirers

Biogen, BioMarin, Lilly and Bristol-Myers Could Be in Crosshairs of Acquirers

Yahoo/Guru Focus

Bristol-Myers Squibb

Flag link:

Higher dose of Pfizer-Lilly drug helps reduce back pain in study

Higher dose of Pfizer-Lilly drug helps reduce back pain in study

Yahoo/Reuters

chronic low back pain

clinical trials

opioid alternatives

Flag link:

Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo

Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo

Yahoo/Reuters

Flag link:

Pages